DPIIT recognised startup Government of India
Startup India
Relecken India Private Limited - real estate in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40,455
▲ 53% YoY
Net profit · FY 2025
₹7,200
Net margin 17.8%
EBITDA · FY 2025
₹10,504
EBITDA margin 26%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Relecken India Private Limited
Data last updated:
Relecken India Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 03 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U70200DL2017PTC310105. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sunita Agrawal and Shailesh Dayal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 157 Upper Lobby Level, Eros Boulevard Hotel Holiday Inn Mayur Vihar Phase – 1, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹40,455, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹7,200 (net margin 17.8%) and EBITDA of ₹10,504 (EBITDA margin 26%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 41% over five years.
The company is associated with 1 brand: Relecken.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website relecken.com.
Company details
CIN U70200DL2017PTC310105
Registration Number 310105
Incorporation Date 03 January 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
CIN history
Relecken India has one previous CIN (Corporate Identification Number): U74999DL2017PTC310105. The current CIN is U70200DL2017PTC310105, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U70200DL2017PTC310105 | Current |
| U74999DL2017PTC310105 | Previous |
Key People
Sunita Agrawal Director Shailesh Dayal Director Recognitions & Rankings of Relecken India
Contact details
Relecken India Private Limited's registered office is in Delhi, Delhi.
- Registered AddressB – 157 Upper Lobby Level, Eros Boulevard Hotel Holiday Inn Mayur Vihar Phase – 1, Delhi, India – 110091
- IndustryReal Estate, Real Estate Leasing, Contractual Work
Comprehensive company report
Relecken India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Relecken India operates one associated brand: Relecken. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Corporate consulting services in financial markets, valuation, and legal advisory. | relecken.com |
Business activity
The main business activity of Relecken India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Relecken India Private Limited, buy the company report.
Financials of Relecken India Private Limited
FY 2025 filings availableRelecken India Private Limited reported revenue of ₹40,455 (up 53% YoY) for FY 2025.
Revenue · FY 2025
₹40,455 ▲ 53%
Net profit · FY 2025
₹7,200 margin 17.8%
EBITDA · FY 2025
₹10,504 margin 26%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 45%
5 years · compounded
▼ 41%
EBITDA CAGR growth
3 years · compounded
▲ 160%
5 years · compounded
▲ 16%
Revenue rose 53% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 41%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,504 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7,200 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26% | ||||
| Net Profit Margin | 17.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Relecken India Private Limited, buy the company report.
Board of directors of Relecken India Private Limited
Relecken India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunita Agrawal | Director | 30 Sep 2024 | 2 Years 1 Months | Current |
| Shailesh Dayal Also directs: Eureka Trust Services Private Limited | Director | 30 Sep 2024 | 2 Years 1 Months | Current |
Peer comparison
Relecken India Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ausrine Healthcare Private Limited | ₹43,847 (FY 2025) | -99.0% | Nashik, Maharashtra, India | |||
| Aeka Biochemicals Private Limited | ₹42,373 (FY 2024) | -92.0% | Thiruvananthapuram, Kerala, India | |||
| Igy Immunologix India Private Limited | ₹42,000 (FY 2025) | -98.0% | Hyderabad, Telangana, India | |||
| Mabtree Biologics India Private Limited | ₹41,511 (FY 2023) | -96.0% | Hyderabad, Telangana, India | |||
| Imagining Mono Emeis Collective Association | ₹40,596 (FY 2025) | -78.0% | Pune, Maharashtra, India | |||
| Relecken India Private Limitedthis company | ₹40,455 (FY 2025) | ₹7,200 | 17.8% | 53.0% | Delhi, India | |
| I Aero Sky India Private Limited | ₹40,000 (FY 2024) | Ernakulam, Kerala, India | ||||
| Trueai Solutions Private Limited | ₹40,000 (FY 2024) | 1211.0% | Brahmapur Sadar, Odisha, India | |||
| Prenetics Innovation Labs Private Limited | ₹39,955 (FY 2025) | -100.0% | Chennai, Tamil Nadu, India | |||
| Fortuniax Biotech Private Limited | ₹39,750 (FY 2024) | -88.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Relecken India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Relecken India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relecken India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Relecken India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Relecken India Private Limited, buy the company report.
Recent activity
Relecken India Private Limited has 6 board changes on record since 2024: 2 appointments and 4 cessations. The latest: Harish Rana ceased to be Director on 24 Oct 2024.
AGM
Relecken India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Relecken India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Harish Rana ceased to be Director.
Ceased
Shailesh Dayal ceased to be Additional Director.
Ceased
Sunita Agrawal ceased to be Additional Director.
Ceased
Bhawna Rana ceased to be Director.
Appointed
Shailesh Dayal was appointed as Director.
Appointed
Sunita Agrawal was appointed as Director.
Incorporation
03 Jan 2017
Relecken India Private Limited was registered on 03 Jan 2017 with Roc Delhi & aged 9 years 10 months as per MCA records.
Frequently asked questions
Relecken India is an active private limited company based in Delhi, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 03 January 2017 (9+ years old) and is registered under CIN U70200DL2017PTC310105.
Relecken India has 2 current directors:
- Sunita Agrawal - Director
- Shailesh Dayal - Director
The latest financial statements of Relecken India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
No. Relecken India has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Relecken India is U70200DL2017PTC310105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relecken India was incorporated on 03 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Relecken India by revenue are Ausrine Healthcare Private Limited, Aeka Biochemicals Private Limited, Igy Immunologix India Private Limited, Mabtree Biologics India Private Limited, Imagining Mono Emeis Collective Association and 4 more, all in the same principal business activity (scientific research and development).
Harish Rana ceased to be Director on 24 Oct 2024. Shailesh Dayal ceased to be Additional Director on 22 Oct 2024. Sunita Agrawal ceased to be Additional Director on 22 Oct 2024. Relecken India has 6 board changes on record in total.
Yes, Relecken India is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Relecken India can be reached through the website relecken.com. Its registered office is in Delhi, India.
The registered office of Relecken India is at B – 157 Upper Lobby Level, Eros Boulevard Hotel Holiday Inn Mayur Vihar Phase – 1, Delhi, India – 110091.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages